Showing results (2801-2810 of 3,662) with videos related to
Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|April 24, 2007
Patients' knowledge and experience of adjuvant endocrine therapy for early breast cancer: a European studyYvonne Wengström, Matti Aapro, Susanna Leto di Priolo, et al.Breast (Edinburgh, Scotland)|August 26, 2006
Management of the axilla in women with breast cancerJ R Benson, G Querci della RovereBreast (Edinburgh, Scotland)|August 26, 2006
Microvessel and lymphatic density in tubular carcinoma of the breast: comparative study with invasive low-grade ductal carcinomaSergio Fernandez-Aguilar, Michel Jondet, Thierry Simonart, et al.Breast (Edinburgh, Scotland)|October 19, 2006
Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II studyMario Campone, Pierre Fumoleau, Patrice Viens, et al.Breast (Edinburgh, Scotland)|June 2, 2006
Lupus mastitisIsabel Cerveira, L Costa Matos, António Garrido, et al.Breast (Edinburgh, Scotland)|May 2, 2021
Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008-2017Fabian Riedel, Ann Sophie Hoffmann, Mareike Moderow, et al.Breast (Edinburgh, Scotland)|April 17, 2020
Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty?D B Raphael, N S Russell, J M Immink, et al.Breast (Edinburgh, Scotland)|May 11, 2020
Fertility in Breast Cancer Survivors in the Middle East: A Retrospective StudyHazem I Assi, Rasha T Kakati, Rose Mary Attieh, et al.Breast (Edinburgh, Scotland)|August 3, 2022
Simple oncoplastic breast defect closure improves long-term cosmetic outcome of breast conserving surgery for breast cancer: A randomised controlled trialChristopher Hadjittofi, Hend Almalki, Bahar Mirshekar-Syahkal, et al.Breast (Edinburgh, Scotland)|August 3, 2022
Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survivalAnna van der Voort, Marte C Liefaard, Mette S van Ramshorst, et al.Pageof 367